Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

4.26
0.0000
Post-market: 4.04-0.2200-5.16%19:53 EDT
Volume:44.87K
Turnover:185.62K
Market Cap:6.80M
PE:-0.14
High:4.39
Open:4.26
Low:4.02
Close:4.26
Loading ...

Stocks to Watch: Block, Barnes & Noble Education, HCW Biologics

Dow Jones
·
19 Jul

HCW Biologics Inc. Secures $7 Million License Agreement with WY Biotech

Reuters
·
19 Jul

HCW Biologics Advances Alopecia Areata Treatment with New Phase 1 Study

TIPRANKS
·
12 Jul

HCW Biologics Inc. Regains Full Compliance with Nasdaq Listing Requirements

Reuters
·
26 Jun

HCW Biologics Board Member Resignation and Director Elections

TIPRANKS
·
24 Jun

HCW Biologics Sees Strong Investor Interest in June

TIPRANKS
·
14 Jun

HCW Biologics Meets Nasdaq Listing Requirements in May 2025

TIPRANKS
·
05 Jun

HCW Biologics Inc. Announces $5 Million At-The-Market Follow-On Offering Under NASDAQ Rules

Reuters
·
05 Jun

HCW Biologics Secures $7 Million License Agreement with WY Biotech for Novel Immunotherapy Development

Reuters
·
04 Jun

HCW Biologics Inc. Issues Additional Shares to Armistice Capital, Retains Warrants for 139,000 Shares

Reuters
·
31 May

BUZZ-David Di Pilla's HCW fund surges on partially deferring Healthscope rental payments

Reuters
·
30 May

HCW Biologics Is Maintained at Buy by Maxim Group

Dow Jones
·
29 May

Maxim Group Keeps Their Buy Rating on HCW Biologics (HCWB)

TIPRANKS
·
29 May

HCW Biologics price target lowered to split-adjusted $35 from $120 at Maxim

TIPRANKS
·
29 May

HCW Biologics Issues Shares Through Warrant Exercise

TIPRANKS
·
24 May

HCW Biologics Inc. Announces Armistice Capital Exercises Pre-Funded Warrants for 126,000 Shares, Retains Rights to 210,000 More

Reuters
·
24 May

HCW Biologics Enters Securities Purchase Agreement

TIPRANKS
·
21 May

Director Garrett Scott T Acquires Common Shares of HCW Biologics Inc

Reuters
·
21 May

HCW Biologics Inc. Announces Conversion of Convertible Bridge Notes into Common Stock

Reuters
·
21 May

HCW Biologics Q1 EPS $(0.05) Up From $(0.20) YoY, Sales $5.07K Down From $1.13M YoY

Benzinga
·
16 May